AR and prostate carcinoma: AR signaling not only promotes the growth of prostate cancer epithelial cells but also directly regulates the establishment of the immune microenvironment by inhibiting antigen presentation (e.g., major histocompatibility complex class I (MHC-I) expression) and facilitating the recruitment of immunosuppressive cells (e.g., MDSCs) (98).